Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone
Clinical trial NCT01807221 · COMPLETED
Trial details
- NCT number
- NCT01807221
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-17
- Primary completion
- 2014-11-11
- Enrollment
- 1066
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.